Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01996605 · ClinicalTrials.gov registry record · Phase 2

Efficacy of Spinal Oxytocin in Healthy Volunteers

A Phase 2 study, sponsored by Wake Forest University Health Sciences.

Terminated
Registry status
Phase 2
Development phase
20
Enrollment target

NCT01996605: Clinical Trial Phase 2 study, sponsored by Wake Forest University Health Sciences.

NCT01996605 is a Phase 2 study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 20 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01996605, a Phase 2 study, was terminated before completion, sponsored by Wake Forest University Health Sciences.

TERMINATED
Registry status
Phase 2
Development phase
20 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effect of intrathecal oxytocin on areas and intensity of hyperalgesia and allodynia induced by topical capsaicin.

Primary Outcome

The area of hyperalgesia after the first skin heating following topical capsaicin.

Interventions

  • DRUG Placebo
  • DRUG Oxytocin 15 mcg
  • DRUG Oxytocin 150 mcg

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2014-01-02
Est. Completion 2022-10-10
Phase Phase 2
Wake Forest University Health Sciences

1,140 total trials

Why NCT01996605 stopped before completion

NCT01996605 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.

NCT01996605 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01996605 about?

NCT01996605 is a clinical study titled "Efficacy of Spinal Oxytocin in Healthy Volunteers". The purpose of this study is to determine the effect of intrathecal oxytocin on areas and intensity of hyperalgesia and allodynia induced by topical capsaicin.

What is the current status of trial NCT01996605?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2014-01-02. Estimated completion is 2022-10-10.

What interventions are being tested in trial NCT01996605?

The interventions under investigation include: Placebo (DRUG), Oxytocin 15 mcg (DRUG), Oxytocin 150 mcg (DRUG).

Who is sponsoring clinical trial NCT01996605?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01996605's enrollment target sits among peer trials

20 1805th of 2000 higher than 107 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01996605, the US trial registry maintained by the National Library of Medicine. NCT01996605 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.